These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9401920)

  • 1. Synthetic peptide vaccines: palmitoylation of peptide antigens by a thioester bond increases immunogenicity.
    Beekman NJ; Schaaper WM; Tesser GI; Dalsgaard K; Kamstrup S; Langeveld JP; Boshuizen RS; Meloen RH
    J Pept Res; 1997 Nov; 50(5):357-64. PubMed ID: 9401920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly immunogenic and fully synthetic peptide-carrier constructs targetting GnRH.
    Beekman NJ; Schaaper WM; Turkstra JA; Meloen RH
    Vaccine; 1999 Apr; 17(15-16):2043-50. PubMed ID: 10217605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nature of the bond between peptide and carrier molecule determines the immunogenicity of the construct.
    Beekman NJ; Schaaper WM; Langeveld JP; Boshuizen RS; Meloen RH
    J Pept Res; 2001 Sep; 58(3):237-45. PubMed ID: 11576330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic peptide vaccines against foot-and-mouth disease. I. Duration of the immune response and priming in guinea-pigs, rabbits and mice.
    Murdin AD; Doel TR
    J Biol Stand; 1987 Jan; 15(1):39-51. PubMed ID: 3031077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic peptide vaccines against foot-and-mouth disease. II. Comparison of the response of guinea-pigs, rabbits and mice to various formulations.
    Murdin AD; Doel TR
    J Biol Stand; 1987 Jan; 15(1):53-65. PubMed ID: 3031078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic peptide epitope-based polymers: controlling size and determining the efficiency of epitope incorporation.
    Sadler K; Zeng W; Jackson DC
    J Pept Res; 2002 Sep; 60(3):150-8. PubMed ID: 12213124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of antipeptide antisera.
    Coligan JE; Tam JP; Shao J
    Curr Protoc Neurosci; 2001 May; Chapter 5():Unit 5.6. PubMed ID: 18428505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Priming and induction of anti-rotavirus antibody response by synthetic peptides derived from VP7 and VP4.
    Ijaz MK; Alkarmi TO; el-Mekki AW; Galadari SH; Dar FK; Babiuk LA
    Vaccine; 1995 Mar; 13(4):331-8. PubMed ID: 7793126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system.
    Tam JP
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5409-13. PubMed ID: 3399498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated Fmoc-based solid-phase synthesis of peptide thioesters with self-purification effect and application in the construction of immobilized SH3 domains.
    Mende F; Beisswenger M; Seitz O
    J Am Chem Soc; 2010 Aug; 132(32):11110-8. PubMed ID: 20662535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic peptides against foot-and-mouth disease--immunization with VP1-peptides of type O1-Kaufbeuren.
    Liebermann H; Holl U; Reimann I; Nöckler A; Schäfer D; Thalmann G; Dölling R
    Arch Exp Veterinarmed; 1990; 44(6):883-90. PubMed ID: 1966360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct immunization with synthetic peptidyl-polyamide resin. Comparison with antibody production from free peptide and conjugates with carrier proteins.
    Fischer PM; Comis A; Howden ME
    J Immunol Methods; 1989 Mar; 118(1):119-23. PubMed ID: 2926147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral immune response against proteophosphoglycan surface antigens of Entamoeba histolytica elicited by immunization with synthetic mimotope peptides.
    Melzer H; Baier K; Felici F; von Specht BU; Wiedermann G; Kollaritsch H; Wiedermann U; Duchêne M
    FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):179-83. PubMed ID: 12832123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody Production with Synthetic Peptides.
    Lee BS; Huang JS; Jayathilaka LP; Lee J; Gupta S
    Methods Mol Biol; 2016; 1474():25-47. PubMed ID: 27515072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical and clinical studies on immunogenicity and safety of the HIV-1 p17-based synthetic peptide AIDS vaccine--HGP-30-KLH.
    Naylor PH; Sztein MB; Wada S; Maurer S; Holterman D; Kirkley JE; Naylor CW; Zook BC; Hitzelberg RA; Gibbs CJ
    Int J Immunopharmacol; 1991; 13 Suppl 1():117-27. PubMed ID: 1823903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fmoc synthesis of peptide thioesters without post-chain-assembly manipulation.
    Zheng JS; Chang HN; Wang FL; Liu L
    J Am Chem Soc; 2011 Jul; 133(29):11080-3. PubMed ID: 21714552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the antigenic structure of porcine parvovirus at the level of peptides.
    Kamstrup S; Langeveld J; Bøtner A; Nielsen J; Schaaper WM; Boshuizen RS; Casal JI; Højrup P; Vela C; Meloen R; Dalsgaard K
    Virus Res; 1998 Feb; 53(2):163-73. PubMed ID: 9620208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epimerization in peptide thioester condensation.
    Teruya K; Tanaka T; Kawakami T; Akaji K; Aimoto S
    J Pept Sci; 2012 Nov; 18(11):669-77. PubMed ID: 22972773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of helical organization on immunogenicity and antigenicity of synthetic peptides.
    Gras-Masse H; Jolivet M; Drobecq H; Aubert JP; Beachey EH; Audibert F; Chedid L; Tartar A
    Mol Immunol; 1988 Jul; 25(7):673-8. PubMed ID: 3419439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiopalmitoylated peptides from the peripheral nervous system myelin p0 protein: synthesis, characterization, and neuritogenic properties.
    Beaino W; Trifilieff E
    Bioconjug Chem; 2010 Aug; 21(8):1439-47. PubMed ID: 20715848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.